Medical Program: aldose reductase inhibitor AT-001 in DbCM

James Januzzi MD at ACC24

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
ACC.24
Beneficial effects of GLP-1RA in patients with obesity-related HFpEF and T2D
- Mikhail Kosiborod, MD
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
ACC.24
Targeting cardiac energetics with cardiac mitotrope in nonobstructive HCM
- Martin Maron, MD
Promising results for self-expanding TAVR device in trial with mostly women
Promising results for self-expanding TAVR device in trial with mostly women
ACC.24
Promising results for self-expanding TAVR device in trial with mostly women
- Hadley Wilson, MD
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
ACC.24
Angiotensinogen RNAi therapeutic lowers blood pressure in combination with standard antihypertensive
- Akshay S. Desai, MD